Global Non-Invasive Aesthetic Treatment Market Size, Trends & Analysis - Forecasts to 2026 By Procedure (Injectables [Botulinum Toxin, Calcium Hydroxylapatite, Hyaluronic Acid, Polymer Filler, Collagen], Skin Rejuvenation [Chemical Peel, Laser Skin Resurfacing, Photo Rejuvenation], Others [Hair Removal, Non-Surgical Fat Reduction, Sclerotherapy, Cellulite Treatment]), By End User (Hospitals & Clinics, Dermatology Clinics & Cosmetic Centers and Salons & Spas), By Region (North America, Europe, Asia Pacific, MEA, and CSA), End-User Landscape, Company Market Share Analysis, and Competitor Analysis
The global non-invasive aesthetic treatment market size is projected to grow from USD 4.60 billion in 2021 to USD 9.45 billion by 2026 at a CAGR value of 13.1%.
The increasing number of non-invasive aesthetic/cosmetic treatments performed each year, rising consumer awareness of non-invasive and painless cosmetic treatments, and the increasing availability of technologically advanced and sophisticated medical devices are the primary drivers supporting the growth of the non-invasive aesthetic treatment market. Clinical risks and consequences associated with medical aesthetic treatments, on the other hand, limit market expansion.
These aesthetic treatment are non-invasive or non-surgical and do not require any type of surgical incision. The increased global use of minimally invasive techniques is projected to fuel the non-invasive aesthetic treatment market. Dermal fillers can cure a variety of skin-related disorders, such as wrinkle reduction and the improvement of damaged skin caused by aging, without causing any complexions or discomfort. Hence, the high efficiency and safety of dermal fillers are likely to boost demand for dermal fillers, increasing the market for non-invasive cosmetic treatment.
Aging is seen as a major aesthetic concern. Signs of aging include wrinkles around the eyes or lips, age spots, and drooping skin. However, various non-surgical cosmetic treatments are now available to help soften the effects of aging on the face. Botox, dermal fillers, spider vein therapy, and chemical peels are all common treatments that come under the umbrella of non-invasive aesthetic treatments. Patients nowadays prefer non-invasive cosmetic treatment options because of advantages such as minimum downtime, no scarring, lower cost, and lesser chance of side effects.
The emergence of technically novel technologies, such as a non-invasive body contouring system that employs controlled cooling technology, will open up new growth opportunities during the forecast periods. Other growth drivers include an increasing number of qualified surgeons conducting non-invasive cosmetic operations, and rising product launch strategies in the market.
The increased demand for fillers and injectables such as Botox is linked positively to the market's rise. According to the American Society for Aesthetic Plastic Surgery (ASAPS), around 3.8 million minimally invasive cosmetic operations were performed in the United States in 2019 on people who were above the age of 50. This emphasizes the country's market's great growth possibilities.
Based on the procedure, the non-invasive aesthetic treatment market is segregated into injectables, and skin rejuvenation, among others. In 2020, the injectables procedure category led the market, and accounted for the largest revenue share during the forecast period. Injectables are simple for surgeons to administer and give speedier therapy with better results and less downtime than other methods. Hair removal, fat reduction, sclerotherapy, and cellulite treatment are among the various services offered.
During the forecast period, nonsurgical fat reduction is expected to be the fastest-growing category. Laser hair removal is becoming more popular since it saves time and is less expensive than waxing, shaving, and lotions. Due to the great efficiency of this technique, the skin rejuvenation procedure segment is predicted to develop lucratively.
Based on the type of end-user, the market is segmented into hospitals & clinics, dermatology clinics & cosmetic centers, and salons & spas. Given the increasing number of medical spas globally and the availability of technologically sophisticated equipment, competent experts, and a trained crew that execute effective cosmetic operations, the salons & spas market is expected to develop at the quickest rate during the forecast period of 2021 to 2026. Practitioners have also expressed concern about a drop in patient interest as a result of a significant decrease in income level. The market is likely to see a period of short-term negative growth.
As per the geographical analysis, the market can be classified into North America (the US, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa and Central & South America.
North America is estimated to be the largest market for the non-invasive aesthetic treatment during the mentioned forecast period. Rising minimally invasive cosmetic procedures, supportive reimbursement norms, and increasing demand for non-invasive face surgeries will drive the North American market. Because of the rising demand for cosmetic operations in the area, North America will maintain its dominant position in terms of revenue during the forecast period. According to the American Society for Aesthetic Plastic Surgery (ASAPS), around 3.8 million minimally invasive cosmetic operations were performed in the United States in 2019 on people who were above the age of 50.
During the projection period, Asia Pacific is expected to have the quickest CAGR from 2021 to 2026. Due to rising awareness of cosmetic treatments, expanding medical tourism, and cosmetic device companies, the Asia Pacific region is expected to be a very profitable market. Furthermore, in the developing countries, a growing emphasis on physical attractiveness is likely to boost demand for non-invasive aesthetic treatments.
Hologic, Inc.; Allergan, Inc.; Galderma S.A.; Alma Lasers; Syneron Candela; Johnson & Johnson; Merz Pharma; Lumenis; Solta Medical; Cutera, Inc.; Revance Therapeutics, Inc, are the major players in the non-invasive aesthetic treatment market.
Please note: This is not an exhaustive list of companies profiled in the report.
These players are working on various marketing strategies, including R&D activities, a growing number of collaborations, awareness programs, technological progress, geographical expansion and the launching of new products, in order to increase their market share.
In June 2019, Orange Twist successfully acquired PURE Aesthetics + Wellness to extends its offerings in non-invasive aesthetic treatments portfolio and provide science-based health and wellness programs.
Chapter 1 Methodology
1.1 Market Scope & Definitions
1.2 Estimates & Forecast Calculation
1.3 Historical Data Overview and Validation
1.4 Data Sources
1.4.1 Secondary
1.4.2 Primary
Chapter 2 Report Outlook
2.1 Global Non-Invasive Aesthetic Treatment Market Overview, 2019-2026
2.1.1 Industry Overview
2.1.2 Procedure Overview
2.1.3 End-User Overview
2.1.4 Regional Overview
Chapter 3 Global Non-Invasive Aesthetic Treatment Market Trends
3.1 Market Segmentation
3.2 Industry Background, 2019-2026
3.3 Market Key Trends
3.3.1 Positive Trends
3.3.1.1 Growing geriatric population
3.3.1.2 Increasing beauty consciousness among consumers
3.3.2 Industry challenges
3.3.2.1 Clinical risks and complications associated with medical aesthetic procedures
3.4 Prospective Growth Scenario
3.4.1 Procedure Overview
3.4.2 End-User Overview
3.5 COVID-19 Influence over Industry Growth
3.6 Porter’s Analysis
3.7 PESTEL Analysis
3.8 Value Chain & Supply Chain Analysis
3.9 Regulatory Framework
3.9.1 North America
3.9.2 Europe
3.9.3 APAC
3.9.4 LATAM
3.9.5 MEA
3.10 End-User Overview
3.11 Market Share Analysis, 2020
3.11.1 Company Positioning Overview, 2020
Chapter 4 Global Non-Invasive Aesthetic Treatment Market, By End-User
4.1 End-User Outlook
4.2 Hospitals & Clinics
4.2.1 Market Size, By Region, 2019-2026 (USD Billion)
4.3 Dermatology Clinics & Cosmetic Centers
4.3.1 Market Size, By Region, 2019-2026 (USD Billion)
4.4 Salons & Spas
4.4.1 Market Size, By Region, 2019-2026 (USD Billion)
Chapter 5 Global Non-Invasive Aesthetic Treatment Market, By Procedure
5.1 Procedure Outlook
5.2 Injectables
5.2.1 Market Size, By Region, 2019-2026 (USD Billion)
5.2.1.1 Botulinum Toxin Market Size, By Region, 2019-2026 (USD Billion)
5.2.1.2 Calcium Hydroxylapatite Market Size, By Region, 2019-2026 (USD Billion)
5.2.1.3 Hyaluronic Acid Market Size, By Region, 2019-2026 (USD Billion)
5.2.1.4 Polymer Filler Market Size, By Region, 2019-2026 (USD Billion)
5.2.1.5 Collagen Market Size, By Region, 2019-2026 (USD Billion)
5.3 Skin Rejuvenation
5.3.1 Market Size, By Region, 2019-2026 (USD Billion)
5.3.1.1 Chemical Peel Market Size, By Region, 2019-2026 (USD Billion)
5.3.1.2 Laser Skin Resurfacing Market Size, By Region, 2019-2026 (USD Billion)
5.3.1.3 Photorejuvenation Market Size, By Region, 2019-2026 (USD Billion)
5.4 Others
5.4.1 Market Size, By Region, 2019-2026 (USD Billion)
5.4.1.1 Hair Removal Market Size, By Region, 2019-2026 (USD Billion)
5.4.1.2 Non-Surgical Fat Reduction Market Size, By Region, 2019-2026 (USD Billion)
5.4.1.3 Sclerotherapy Market Size, By Region, 2019-2026 (USD Billion)
5.4.1.4 Cellulite Treatment Market Size, By Region, 2019-2026 (USD Billion)
Chapter 6 Global Non-Invasive Aesthetic Treatment Market, By Region
6.1 Regional outlook
6.2 North America
6.2.1 Market Size, By Country 2019-2026 (USD Billion)
6.2.2 Market Size, By End-User, 2019-2026 (USD Billion)
6.2.3 Market Size, By Procedure, 2019-2026 (USD Billion)
6.2.4 U.S.
6.2.4.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.2.4.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.2.5 Canada
6.2.5.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.2.5.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.3 Europe
6.3.1 Market Size, By Country 2019-2026 (USD Billion)
6.3.2 Market Size, By End-User, 2019-2026 (USD Billion)
6.3.3 Market Size, By Procedure, 2019-2026 (USD Billion)
6.3.4 Germany
6.3.4.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.3.4.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.3.5 UK
6.3.5.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.3.5.2 Market Si/ze, By Procedure, 2019-2026 (USD Billion)
6.3.6 France
6.3.6.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.3.6.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.3.7 Italy
6.3.7.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.3.7.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.3.8 Spain
6.3.8.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.3.8.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.3.9 Russia
6.3.9.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.3.9.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.4 Asia Pacific
6.4.1 Market Size, By Country 2019-2026 (USD Billion)
6.4.2 Market Size, By End-User, 2019-2026 (USD Billion)
6.4.3 Market Size, By Procedure, 2019-2026 (USD Billion)
6.4.4 China
6.4.4.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.4.4.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.4.5 India
6.4.5.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.4.5.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.4.6 Japan
6.4.6.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.4.6.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.4.7 Australia
6.4.7.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.4.7.2 Market size, By Procedure, 2019-2026 (USD Billion)
6.4.8 South Korea
6.4.8.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.4.8.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.5 Latin America
6.5.1 Market Size, By Country 2019-2026 (USD Billion)
6.5.2 Market Size, By End-User, 2019-2026 (USD Billion)
6.5.3 Market Size, By Procedure, 2019-2026 (USD Billion)
6.5.4 Brazil
6.5.4.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.5.4.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.5.5 Mexico
6.5.5.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.5.5.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.5.6 Argentina
6.5.6.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.5.6.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.6 MEA
6.6.1 Market Size, By Country 2019-2026 (USD Billion)
6.6.2 Market Size, By End-User, 2019-2026 (USD Billion)
6.6.3 Market Size, By Procedure, 2019-2026 (USD Billion)
6.6.4 Saudi Arabia
6.6.4.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.6.4.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.6.5 UAE
6.6.5.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.6.5.2 Market Size, By Procedure, 2019-2026 (USD Billion)
6.6.6 South Africa
6.6.6.1 Market Size, By End-User, 2019-2026 (USD Billion)
6.6.6.2 Market Size, By Procedure, 2019-2026 (USD Billion)
Chapter 7 Company Landscape
7.1 Competitive Analysis, 2020
7.2 Hologic, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Strategic Positioning
7.2.4 Info-Graphic Analysis
7.3 Allergan, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Strategic Positioning
7.3.4 Info-Graphic Analysis
7.4 Galderma S.A.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Strategic Positioning
7.4.4 Info-Graphic Analysis
7.5 Alma Lasers
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Strategic Positioning
7.5.4 Info-Graphic Analysis
7.6 Syneron Candela
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Strategic Positioning
7.6.4 Info-Graphic Analysis
7.7 Johnson & Johnson
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Strategic Positioning
7.7.4 Info-Graphic Analysis
7.8 Merz Pharma
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Strategic Positioning
7.8.4 Info-Graphic Analysis
7.9 Lumenis
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Strategic Positioning
7.9.4 Info-Graphic Analysis
7.10 Solta Medical
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Strategic Positioning
7.10.4 Info-Graphic Analysis
7.11 Cutera, Inc.
7.11.1 Company Overview
7.11.2 Financial Analysis
7.11.3 Strategic Positioning
7.11.4 Info-Graphic Analysis
7.12 Revance Therapeutics Inc.
7.12.1 Company Overview
7.12.2 Financial Analysis
7.12.3 Strategic Positioning
7.12.4 Info-Graphic Analysis
7.13 Other Companies
7.13.1 Company Overview
7.13.2 Financial Analysis
7.13.3 Strategic Positioning
7.13.4 Info-Graphic Analysis
The Global Non-Invasive Aesthetic Treatment Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Non-Invasive Aesthetic Treatment Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS